DSG2 and Miyoshi myopathy: Future work will focus on confirming the importance of DSG2 to BM homing and disease progression in vivo and on developing DSG2‐based assays to more accurately stratify MM patients according to disease risk at the time of diagnosis and thereby improve clinical outcome.